Actively Recruiting
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
Led by Amivas Inc. · Updated on 2024-01-30
25
Participants Needed
1
Research Sites
368 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
CONDITIONS
Official Title
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient received IV Artesunate
- Patient was pregnant while receiving IV Artesunate
- Patient was at least 15 years of age
- Patient or legal guardian/representative gave consent for the study and to collect data from her physicians
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
4C Pharma Solutions
Piscataway, New Jersey, United States, 08854
Actively Recruiting
Research Team
K
Katrina Riggs
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here